The global Knee Replacement Surgery Market is experiencing steady expansion, fueled by the growing burden of orthopedic disorders, technological advancements in surgical procedures, and increasing demand for minimally invasive treatment approaches. According to recent market research, the market is projected to grow from USD 12.00 billion in 2025 to USD 16.17 billion by 2030, registering a CAGR of 6.1% during the forecast period.
As healthcare systems worldwide focus on improving patient outcomes and reducing recovery times, innovations in knee replacement procedures, implants, and biologic therapies are reshaping the orthopedic landscape.
Rising Prevalence of Arthritis Driving Market Expansion
One of the primary factors contributing to market growth is the increasing incidence of osteoarthritis and rheumatoid arthritis. These conditions are among the leading causes of chronic pain and disability, particularly among aging populations. As life expectancy increases and obesity rates continue to rise, the number of individuals suffering from degenerative joint diseases is also growing.
Patients experiencing severe joint deterioration often require knee replacement surgery to restore mobility and improve quality of life. Consequently, healthcare providers are witnessing a significant increase in both primary and revision total knee arthroplasty procedures, creating substantial opportunities for device manufacturers and healthcare facilities.
Minimally Invasive Surgery Transforming Patient Care
The adoption of minimally invasive surgical (MIS) techniques is emerging as a major growth catalyst for the knee replacement surgery market. Compared with conventional procedures, minimally invasive approaches provide several advantages, including:
- Reduced postoperative pain
- Shorter hospital stays
- Faster rehabilitation and recovery
- Lower risk of complications
- Improved patient satisfaction
Advancements in robotic-assisted surgery, computer navigation systems, and precision instruments are further enhancing surgical accuracy and outcomes. These technologies enable surgeons to achieve better implant alignment and reduce tissue damage, making knee replacement procedures safer and more effective.
As healthcare providers increasingly embrace these innovations, the demand for advanced surgical devices and implants is expected to rise considerably throughout the forecast period.
Orthobiologics Emerging as a High-Growth Segment
Based on product type, the market is segmented into knee implants, knee braces and support systems, and orthobiologics. Among these categories, the orthobiologics segment is anticipated to witness particularly strong growth over the coming years.
Orthobiologics utilize naturally occurring substances to promote tissue regeneration and accelerate healing. Popular therapies include:
- Platelet-Rich Plasma (PRP) injections
- Stem cell therapies
- Hyaluronic acid injections
These treatment modalities are increasingly being adopted as non-surgical alternatives for managing early and moderate osteoarthritis. Many patients prefer these less invasive solutions because they can delay or even eliminate the need for surgery while enhancing joint function and reducing pain.
Growing awareness regarding regenerative medicine and increasing investments in biologic research are expected to further drive demand for orthobiologics globally.
Osteoarthritis and Rheumatoid Arthritis Applications Leading Growth
By application, the knee replacement surgery market encompasses:
- Osteoarthritis and rheumatoid arthritis
- Degenerative diseases
- Cancer
- Other applications
Among these segments, osteoarthritis and rheumatoid arthritis are projected to record the highest growth rates during the study period.
The increasing prevalence of these chronic conditions is creating substantial demand for orthopedic interventions. Aging populations, sedentary lifestyles, obesity, and sports-related injuries are contributing to the rising incidence of joint disorders worldwide.
Additionally, the integration of orthobiologics into orthopedic procedures is gaining momentum. These biologically derived products enhance tissue repair mechanisms and support faster healing, improving overall treatment outcomes.
The growing elderly population is another key driver. Older adults are more susceptible to cartilage degeneration and joint diseases, leading to increased demand for knee surgery devices and replacement procedures.
Hospitals Continue to Dominate the End-User Segment
Based on end users, the market is divided into:
- Hospitals
- Ambulatory Surgery Centers (ASCs)
- Orthopedic clinics
Hospitals accounted for the largest share of the market in 2024. Their dominance can be attributed to the availability of advanced surgical infrastructure, highly skilled orthopedic specialists, and comprehensive postoperative care services.
However, ambulatory surgery centers are expected to experience significant growth in the coming years. Improvements in anesthesia techniques, enhanced surgical technologies, and evolving reimbursement policies are enabling more orthopedic procedures to be performed in outpatient settings.
ASCs offer several advantages, including:
- Reduced treatment costs
- Shorter patient stays
- Increased operational efficiency
- Lower risk of hospital-acquired infections
- Faster patient recovery
As a result, an increasing number of knee arthroplasties are expected to shift toward outpatient facilities, creating strong growth opportunities for the ASC segment.
Technological Innovations Reshaping the Industry
The knee replacement surgery market is undergoing rapid technological transformation. Emerging technologies such as robotic-assisted systems, smart implants, 3D printing, and artificial intelligence are revolutionizing orthopedic care.
Robotic platforms provide enhanced precision during surgery, while personalized implants manufactured through 3D printing improve anatomical fit and patient outcomes. Furthermore, AI-powered surgical planning and data analytics are helping physicians optimize treatment strategies and reduce complications.
These advancements are expected to improve procedural efficiency and contribute significantly to market growth over the next several years.
Competitive Landscape
The market is highly competitive, with several established players focusing on innovation, product development, and strategic collaborations. Major companies operating in the global knee replacement surgery market include:
- Zimmer Biomet (US)
- Stryker (US)
- Johnson & Johnson, Inc. (US)
- Smith+Nephew PLC (UK)
- B. Braun (Germany)
These organizations are investing heavily in research and development to introduce next-generation implants, robotic surgical systems, and biologic therapies aimed at improving patient outcomes and expanding their market presence.
Future Outlook
The future of the knee replacement surgery market appears highly promising. Rising rates of arthritis and other orthopedic disorders, coupled with increasing demand for minimally invasive procedures and regenerative therapies, are expected to fuel sustained market expansion through 2030.
Moreover, continuous advancements in implant materials, robotic-assisted surgery, and orthobiologics are transforming the treatment landscape and enhancing patient experiences. As healthcare providers focus on delivering more personalized and efficient orthopedic care, the market is set to witness robust growth and significant technological evolution in the years ahead.
With projected revenues reaching USD 16.17 billion by 2030, the global knee replacement surgery market will remain a vital component of the orthopedic healthcare industry, offering innovative solutions to address the growing burden of joint diseases worldwide.